These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8883615)

  • 21. Why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.
    Agostini C; Semenzato G
    Blood; 2002 Mar; 99(5):1876-7. PubMed ID: 11871389
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.
    Liu H; Ohashi T; Masuda T; Zhou X; Kubo M; Kannagi M
    Viral Immunol; 2003; 16(3):381-93. PubMed ID: 14583152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring HIV-1-specific T cell immunity: how valid are current assays?
    D'Souza MP; Altfeld M
    J Infect Dis; 2008 Feb; 197(3):337-9. PubMed ID: 18184092
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.
    Kolber MA
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1002-7. PubMed ID: 15539497
    [No Abstract]   [Full Text] [Related]  

  • 25. Cellular immunity in breast milk: implications for postnatal transmission of HIV-1 to the infant.
    Sabbaj S; Ibegbu CC; Kourtis AP
    Adv Exp Med Biol; 2012; 743():161-9. PubMed ID: 22454348
    [No Abstract]   [Full Text] [Related]  

  • 26. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 27. Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.
    Dalod M; Fiorentino S; Delamare C; Rouzioux C; Sicard D; Guillet JG; Gomard E
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):497-506. PubMed ID: 8679305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-unrestricted killing of HIV-1 gag protein-expressing CD4 T cells by gag-specific CD8 cytotoxic T cells.
    Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM
    AIDS; 1999 Aug; 13(12):1583-4. PubMed ID: 10465085
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV-specific CD8+ T-cell immune responses and viral replication.
    Buseyne F; Rivière Y
    AIDS; 1993 Nov; 7 Suppl 2():S81-5. PubMed ID: 7909230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New observations on CD8 cell responses.
    Nixon DF; Aandahl EM; Sandberg JK
    AIDS; 2003; 17 Suppl 4():S61-5. PubMed ID: 15080181
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of HIV-1 infection by soluble factors of the immune response.
    DeVico AL; Gallo RC
    Nat Rev Microbiol; 2004 May; 2(5):401-13. PubMed ID: 15100693
    [No Abstract]   [Full Text] [Related]  

  • 34. Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.
    Blish CA; Dogan OC; Jaoko W; McClelland RS; Mandaliya K; Odem-Davis KS; Richardsonb BA; Overbaugh J
    AIDS; 2012 Mar; 26(5):643-6. PubMed ID: 22210637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors related to loss of HIV-specific cytotoxic T lymphocyte activity.
    Gamberg J; Barrett L; Bowmer MI; Howley C; Grant M
    AIDS; 2004 Mar; 18(4):597-604. PubMed ID: 15090764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Questions about CD8+ anti-HIV lymphocytes in the control of HIV infection.
    Levy JP
    Antibiot Chemother (1971); 1996; 48():13-20. PubMed ID: 8726501
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic-T-cell responses in early HIV-1 infection.
    Phillips AN
    N Engl J Med; 1998 Feb; 338(9):622-3. PubMed ID: 9480442
    [No Abstract]   [Full Text] [Related]  

  • 38. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.
    Barker E; Mackewicz CE; Levy JA
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11135-9. PubMed ID: 7479952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
    Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
    J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.